U.S. FDA: Rule on the petition that resistant starch reduces the risk of Type 2 Diabetes

Recent news

FDA approves Resistant Starch Health Claim

On December 12, 2016, The US Food and Drug Administration issued their ruling on the Resistant Starch health claim petition. They approved the following claim: "High-amylose maize resistant starch may reduce the risk of type 2 diabetes. FDA has concluded that there is limited scientific evidence for this claim." A hearty thank you to ALL who signed this petition and let the FDA know that we are interested in this information. I so appreciate your help and support. This is the highest claim achieved for a dietary ingredient or food reducing the risk of type 2 diabetes! For those not familiar with qualified health claim language, this is a Level C qualified health claim. Other ingredients submitted within the last few years include whole grains and psyllium, both rated a lower Level D for their potential benefit in reducing the risk of type 2 diabetes. This qualified health claim will elevate the profile of resistant starch within the regulatory and health communities. I am hoping that the higher profile will encourage the U.S. National Institutes of Health and other funders of large clinical studies to continue this valuable research.

Rhonda Witwer
5 years ago